|
1
|
Cheng X and Klaassen CD: Tissue
distribution, ontogeny, and hormonal regulation of xenobiotic
transporters in mouse kidneys. Drug Metab Dispos. 37:2178–2185.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Klaassen CD and Aleksunes LM: Xenobiotic,
bile acid, and cholesterol transporters: Function and regulation.
Pharmacol Rev. 62:1–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sweeney DE, Vallon V, Rieg T, Wu W,
Gallegos TF and Nigam SK: Functional maturation of drug
transporters in the developing, neonatal, and postnatal kidney. Mol
Pharmacol. 80:147–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brouwer KL, Aleksunes LM, Brandys B,
Giacoia GP, Knipp G, Lukacova V, Meibohm B, Nigam SK, Rieder M and
De Wildt SN: Pediatric Transporter Working Group: Human ontogeny of
drug transporters: Review and recommendations of the pediatric
transporter working group. Clin Pharmacol Ther. 98:266–287. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Zwart L, Scholten M, Monbaliu JG,
Annaert PP, Van Houdt JM, Van den Wyngaert I, De Schaepdrijver LM,
Bailey GP, Coogan TP, Coussement WC and Mannens GS: The ontogeny of
drug metabolizing enzymes and transporters in the rat. Reprod
Toxicol. 26:220–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bridges CC, Zalups RK and Joshee L:
Toxicological significance of renal Bcrp: Another potential
transporter in the elimination of mercuric ions from proximal
tubular cells. Toxicol Appl Pharmacol. 285:110–117. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nigam SK, Bush KT, Martovetsky G, Ahn SY,
Liu HC, Richard E, Bhatnagar V and Wu W: The organic anion
transporter (OAT) family: A systems biology perspective. Physiol
Rev. 95:83–123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lash LH, Hueni SE, Putt DA and Zalups RK:
Role of organic anion and amino acid carriers in transport of
inorganic mercury in rat renal basolateral membrane vesicles:
Influence of compensatory renal growth. Toxicol Sci. 88:630–644.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Di Giusto G, Anzai N, Ruiz ML, Endou H and
Torres AM: Expression and function of Oat1 and Oat3 in rat kidney
exposed to mercuric chloride. Arch Toxicol. 83:887–897. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zalups RK and Ahmad S: Handling of
cysteine S-conjugates of methylmercury in MDCK cells expressing
human OAT1. Kidney Int. 68:1684–1699. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Torres AM, Dnyanmote AV, Bush KT, Wu W and
Nigam SK: Deletion of multispecific organic anion transporter
Oat1/Slc22a6 protects against mercury-induced kidney injury. J Biol
Chem. 286:26391–26395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xue X, Gong LK, Maeda K, Luan Y, Qi XM,
Sugiyama Y and Ren J: Critical role of organic anion transporters 1
and 3 in kidney accumulation and toxicity of aristolochic acid I.
Mol Pharm. 8:2183–2192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saito H: Pathophysiological regulation of
renal SLC22A organic ion transporters in acute kidney injury:
Pharmacological and toxicological implications. Pharmacol Ther.
125:79–91. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim HJ, Park DJ, Kim JH, Jeong EY, Jung
MH, Kim TH, Yang JI, Lee GW, Chung HJ and Chang SH: Glutamine
protects against cisplatin-induced nephrotoxicity by decreasing
cisplatin accumulation. J Pharmacol Sci. 127:117–126. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Soodvilai S, Nantavishit J, Muanprasat C
and Chatsudthipong V: Renal organic cation transporters mediated
cadmium-induced nephrotoxicity. Toxicol Lett. 204:38–42. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Q, Guo D, Dong Z, Zhang W, Zhang L,
Huang SM, Polli JE and Shu Y: Ondansetron can enhance
cisplatin-induced nephrotoxicity via inhibition of multiple toxin
and extrusion proteins (MATEs). Toxicol Appl Pharmacol.
273:100–109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wen X, Gibson CJ, Yang I, Buckley B,
Goedken MJ, Richardson JR and Aleksunes LM: MDR1 transporter
protects against paraquat-induced toxicity in human and mouse
proximal tubule cells. Toxicol Sci. 141:475–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zalups RK, Joshee L and Bridges CC: Novel
Hg2+-induced nephropathy in rats and mice lacking Mrp2: Evidence of
axial heterogeneity in the handling of Hg2+ along the proximal
tubule. Toxicol Sci. 142:250–260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bridges CC, Joshee L and Zalups RK:
Placental and fetal disposition of mercuric ions in rats exposed to
methylmercury: Role of Mrp2. Reprod Toxicol. 34:628–634. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yonezawa A and Inui K: Organic cation
transporter OCT/SLC22A and H(+)/organic cation antiporter
MATE/SLC47A are key molecules for nephrotoxicity of platinum
agents. Biochem Pharmacol. 81:563–568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hazelhoff MH, Bulacio RP and Torres AM:
Gender related differences in kidney injury induced by mercury. Int
J Mol Sci. 13:10523–10536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bridges CC, Joshee L and Zalups RK: Aging
and the disposition and toxicity of mercury in rats. Exp Gerontol.
53:31–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alnouti Y, Petrick JS and Klaassen CD:
Tissue distribution and ontogeny of organic cation transporters in
mice. Drug Metab Dispos. 34:477–482. 2006.PubMed/NCBI
|
|
24
|
Lickteig AJ, Cheng X, Augustine LM,
Klaassen CD and Cherrington NJ: Tissue distribution, ontogeny and
induction of the transporters Multidrug and toxin extrusion (MATE)
1 and MATE2 mRNA expression levels in mice. Life Sci. 83:59–64.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Slitt AL, Cherrington NJ, Hartley DP,
Leazer TM and Klaassen CD: Tissue distribution and renal
developmental changes in rat organic cation transporter mRNA
levels. Drug Metab Dispos. 30:212–219. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Buist SC, Cherrington NJ, Choudhuri S,
Hartley DP and Klaassen CD: Gender-specific and developmental
influences on the expression of rat organic anion transporters. J
Pharmacol Exp Ther. 301:145–151. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakajima N, Sekine T, Cha SH, Tojo A,
Hosoyamada M, Kanai Y, Yan K, Awa S and Endou H: Developmental
changes in multispecific organic anion transporter 1 expression in
the rat kidney. Kidney Int. 57:1608–1616. 2000.PubMed/NCBI
|
|
28
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hou WY, Xu SF, Zhu QN, Lu YF, Cheng XG and
Liu J: Age- and sex-related differences of organic
anion-transporting polypeptide gene expression in livers of rats.
Toxicol Appl Pharmacol. 280:370–377. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jia W, Du F, Liu X, Jiang R, Xu F, Yang J,
Li L, Wang F, Olaleye OE, Dong J and Li C: Renal tubular secretion
of tanshinol: Molecular mechanisms, impact on its systemic
exposure, and propensity for dose-related nephrotoxicity and for
renal herb-drug interactions. Drug Metab Dispos. 43:669–678. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Komazawa H, Yamaguchi H, Hidaka K, Ogura
J, Kobayashi M and Iseki K: Renal uptake of substrates for organic
anion transporters Oat1 and Oat3 and organic cation transporters
Oct1 and Oct2 is altered in rats with adenine-induced chronic renal
failure. J Pharm Sci. 102:1086–1094. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Preising C, Schneider R, Bucher M, Gekle M
and Sauvant C: Regulation of expression of renal organic anion
transporters OAT1 and OAT3 in a model of ischemia/reperfusion
injury. Cell Physiol Biochem. 37:1–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sui Y, Yang H, Tian XZ, Liu J and Shi JZ:
Effect of Zhusha Anshen pill, cinnabar, HgS, HgCl2 and MeHg on gene
expression of renal transporters in mice. Zhongguo Zhong Yao Za
Zhi. 40:506–510. 2015.(In Chinese). PubMed/NCBI
|
|
34
|
Zhu QN, Lu YF, Shi JZ, Wu Q, Zhang F, Shi
JS and Liu J: Distinct effect of Wansheng Huafeng Dan containing
ardisia crenata on renal transporters, mercury accumulation and
Kim-1 expression from mercuric chloride. Zhongguo Zhong Yao Za Zhi.
39:1892–1896. 2014.(In Chinese). PubMed/NCBI
|
|
35
|
Wegner W, Burckhardt BC, Burckhardt G and
Henjakovic M: Male-dominant activation of rat renal organic anion
transporter 1 (Oat1) and 3 (Oat3) expression by transcription
factor BCL6. PloS One. 7:e355562012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pavlova A, Sakurai H, Leclercq B, Beier
DR, Yu AS and Nigam SK: Developmentally regulated expression of
organic ion transporters NKT (OAT1), OCT1, NLT (OAT2) and Roct. Am
J Physiol Renal Physiol. 278:F635–F643. 2000.PubMed/NCBI
|
|
37
|
Ljubojevic M, Breljak D, Herak-Kramberger
CM, Anzai N and Sabolić I: Expression of basolateral organic anion
and cation transporters in experimental cadmium nephrotoxicity in
rat kidney. Arch Toxicol. 90:525–541. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tzvetkov MV, Vormfelde SV, Balen D,
Meineke I, Schmidt T, Sehrt D, Sabolić I, Koepsell H and
Brockmöller J: The effects of genetic polymorphisms in the organic
cation transporters OCT1, OCT2, and OCT3 on the renal clearance of
metformin. Clin Pharmacol Ther. 86:299–306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kuo KL, Zhu H, McNamara PJ and Leggas M:
Localization and functional characterization of the rat Oatp4c1
transporter in an in vitro cell system and rat tissues. PLos One.
7:e396412012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Masereeuw R, Mutsaers HA, Toyohara T, Abe
T, Jhawar S, Sweet DH and Lowenstein J: The kidney and uremic toxin
removal: Glomerulus or tubule? Semin Nephrol. 34:191–208. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yamaguchi H, Sugie M, Okada M, Mikkaichi
T, Toyohara T, Abe T, Goto J, Hishinuma T, Shimada M and Mano N:
Transport of estrone 3-sulfate mediated by organic anion
transporter OATP4C1: Estrone 3-sulfate binds to the different
recognition site for digoxin in OATP4C1. Drug Metab Pharmacokinet.
25:314–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chu XY, Bleasby K, Yabut J, Cai X, Chan
GH, Hafey MJ, Xu S, Bergman AJ, Braun MP, Dean DC and Evers R:
Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by
human organic anion transporter 3, organic anion transporting
polypeptide 4C1 and multidrug resistance P-glycoprotein. J
Pharmacol Exp Ther. 321:673–683. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ma L, Qin Y, Shen Z, Bi H, Hu H, Huang M,
Zhou H, Yu L, Jiang H and Zeng S: Aristolochic acid I is a
substrate of BCRP but not P-glycoprotein or MRP2. J Ethnopharmacol.
172:430–435. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Konieczna A, Erdösová B, Lichnovská R,
Jandl M, Cizkova K and Ehrmann J: Differential expression of ABC
transporters (MDR1, MRP1, BCRP) in developing human embryos. J Mol
Histol. 42:567–574. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tanaka Y, Slitt AL, Leazer TM, Maher JM
and Klaassen CD: Tissue distribution and hormonal regulation of the
breast cancer resistance protein (Bcrp/Abcg2) in rats and mice.
Biochem Biophys Res Commun. 326:181–187. 2005.PubMed/NCBI
|
|
46
|
Cui YJ, Cheng X, Weaver YM and Klaassen
CD: Tissue distribution, gender-divergent expression, ontogeny, and
chemical induction of multidrug resistance transporter genes
(Mdr1a, Mdr1b, Mdr2) in mice. Drug Metab Dispos. 37:203–210. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Prevoo B, Miller DS, van de Water FM,
Wever KE, Russel FG, Flik G and Masereeuw R: Rapid, nongenomic
stimulation of multidrug resistance protein 2 (Mrp2) activity by
glucocorticoids in renal proximal tubule. J Pharmacol Exp Ther.
338:362–371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bridges CC, Joshee L, van den Heuvel JJ,
Russel FG and Zalups RK: Glutathione status and the renal
elimination of inorganic mercury in the Mrp2(−/−) mouse. PLoS One.
8:e735592013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
El-Sheikh AA, Koenderink JB, Wouterse AC,
van den Broek PH, Verweij VG, Masereeuw R and Russel FG: Renal
glucuronidation and multidrug resistance protein 2-/ multidrug
resistance protein 4-mediated efflux of mycophenolic acid:
Interaction with cyclosporine and tacrolimus. Transl Res.
164:46–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Maher JM, Slitt AL, Cherrington NJ, Cheng
X and Klaassen CD: Tissue distribution and hepatic and renal
ontogeny of the multidrug resistance-associated protein (Mrp)
family in mice. Drug Metab Dispos. 33:947–955. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Staud F, Cerveny L, Ahmadimoghaddam D and
Ceckova M: Multidrug and toxin extrusion proteins (MATE/SLC47);
role in pharmacokinetics. Int J Biochem Cell Biol. 45:2007–2011.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Muller F, König J, Hoier E, Mandery K and
Fromm MF: Role of organic cation transporter OCT2 and multidrug and
toxin extrusion proteins MATE1 and MATE2-K for transport and drug
interactions of the antiviral lamivudine. Biochem Pharmacol.
86:808–815. 2013. View Article : Google Scholar : PubMed/NCBI
|
